This is Skoko's TypePad Profile.
Join TypePad and start following Skoko's activity
Skoko
Recent Activity
Thank you Mark, for the summary of my presentation!
I wanted to add one clarification to my comment above:
I absolutely agree about the growing importance of social platforms in engaging with one's different stakeholders. We have to find more ways to participate there as well - where it makes sense: that is when we are sure to reach the audiences and can bring value to the conversation for a longer term.
But I think that providers are missing an important chance when rushing to Facebook et al "to be where everybody is" (but maybe not exactly waiting for me) - without engaging with the people who are already coming to their own web estate. Here, people are coming to in no small numbers either, plus they come with a declared interest in the offer and do not stumble upon it by accident.
Giving all stakeholders a chance to communicate with you and easily share content that they find interesting is a great chance for us to learn to better understand their needs and how to engage on other platforms as well.
Sabine
Report From ExL Digital Pharma Conference in Berlin - Roche on Roche
Hello from Berlin! The Second Annual Digital Pharma ExL Conference began today at Bayer-Schering headquarters in Berlin, Germany. It has been a great experience for me to see where Europe is compared to the U.S. and I hope to share that in postings that get put up here on Eye on FDA this ...
Skoko is now following The Typepad Team
Apr 3, 2010
Subscribe to Skoko’s Recent Activity
